Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Cardlytics (Nasdaq: CDLX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of its IPO
February 9, 2018 6:00 AM ESTADVISORY, Feb. 09, 2018 (GLOBE NEWSWIRE) --
What:Â Cardlytics (Nasdaq: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
In honor of the occasion, Scott Grimes, CEO & Co-Founder & Lynne Laube, COO & Co-Founder, will ring the Opening Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Friday, February 9, 2018 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â
Cardlytics Media... More
Cardlytics Announces Pricing of Initial Public Offering
February 8, 2018 6:41 PM ESTATLANTA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cardlytics, Inc., a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares of common stock. Cardlytics common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol CDLX on February 9, 2018. The... More
